Skip to main content
Log in

Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS)

  • Brief Communication
  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Objective

The Patient-Oriented Prostate Utility Scale (PORPUS) is a combined profile and utility-based quality of life measure for prostate cancer patients. Our objectives were to adapt the PORPUS into Spanish and to assess its acceptability, reliability, and validity.

Methods

The PORPUS was adapted into Spanish using forward and back translations and cognitive debriefing. PORPUS was administered jointly with the SF-36 and the Expanded Prostate Index Composite (EPIC) to 480 Spanish prostate cancer patients treated with radical prostatectomy or radiotherapy. The Spanish PORPUS scores’ distribution and reliability were examined and compared with the original instrument. To evaluate construct validity, relationships were assessed between PORPUS and other instruments (testing hypotheses of the original PORPUS study), and among known groups defined by side effect severity.

Results

Reliability coefficient was 0.76 (similar to the original PORPUS’ 0.81). Spanish PORPUS items presented correlations ranging 0.57–0.88 with the corresponding EPIC domains, as in the original PORPUS study (0.60–0.83). Both PORPUS-P and PORPUS-U showed significant differences and large effect sizes (0.94–1.90) when comparing severe versus no problem groups on urinary, bowel, sexual and hormonal side effects defined by EPIC.

Conclusions

A conceptually equivalent Spanish version was obtained, with high reliability and good construct validity, similar to the original Canadian PORPUS version. It can therefore be used to measure health-related quality of life and utilities in Spanish prostate cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Rnic, K., Linden, W., Tudor, I., Pullmer, R., & Vodermaier, A. (2013). Measuring symptoms in localized prostate cancer: A systematic review of assessment instruments. Prostate Cancer and Prostatic Diseases, 16, 111–122.

    Article  PubMed  CAS  Google Scholar 

  2. Ritvo, P., Irvine, J., Naglie, G., Tomlinson, G., Bezjak, A., Matthew, A., et al. (2005). Reliability and validity of the PORPUS, a combined psychometric and utility-based quality-of-life instrument for prostate cancer. Journal of Clinical Epidemiology, 58, 466–474.

    Article  PubMed  Google Scholar 

  3. Tomlinson, G., Bremner, K. E., Ritvo, P., Naglie, G., & Krahn, M. D. (2012). Development and validation of a utility weighting function for the Patient-Oriented Prostate Utility Scale (PORPUS). Medical Decision Making, 32, 11–30.

    Article  PubMed  Google Scholar 

  4. Krahn, M., Ritvo, P., Irvine, J., Tomlinson, G., Bezjak, A., Trachtenberg, J., et al. (2000). Construction of the Patient-Oriented Prostate Utility Scale (PORPUS): A multiattribute health state classification system for prostate cancer. Journal of Clinical Epidemiology, 53, 920–930.

    Article  PubMed  CAS  Google Scholar 

  5. Ferrer, M., Suarez, J. F., Guedea, F., Fernandez, P., Macias, V., Marino, A., et al. (2008). Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. International Journal of Radiation Oncology Biology Physics, 72, 421–432.

    Article  Google Scholar 

  6. Alonso, J., Prieto, L., & Anto, J. M. (1995). The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): An instrument for measuring clinical results. Medicina Clinica (Barc), 104, 771–776.

    CAS  Google Scholar 

  7. Batista-Miranda, J. E., Sevilla-Cecilia, C., Torrubia, R., Musquera, M., Huguet-Perez, J., Ponce, D. L. X., et al. (2003). Quality of life in prostate cancer patients and controls: Psychometric validation of the FACTP-4 in Spanish, and relation to urinary symptoms. Archivos Espanoles de Urologia, 56, 447–454.

    PubMed  Google Scholar 

  8. Ferrer, M., Garin, O., Pera, J., Prats, J. M., Mendivil, J., Alonso, J., et al. (2009). Evaluation of the quality of life of patients with localized prostate cancer: Validation of the Spanish version of the EPIC. Medicina Clinica (Barc), 132, 128–135.

    Article  Google Scholar 

  9. Pardo, Y., Guedea, F., Aguilo, F., Fernandez, P., Macias, V., Marino, A., et al. (2010). Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. Journal of Clinical Oncology, 28, 4687–4696.

    Article  PubMed  Google Scholar 

  10. Torvinen, S., Farkkila, N., Sintonen, H., Saarto, T., Roine, R. P., & Taari, K. (2013). Health-related quality of life in prostate cancer. Acta Oncologica, 52, 1094–1101.

    Article  PubMed  Google Scholar 

  11. Scientific Advisory Committee of the Medical Outcomes Trust. (2002). Assessing health status and quality-of-life instruments: Attributes and review criteria. Quality of Life Research, 11, 193–205.

    Article  Google Scholar 

  12. Krahn, M., Bremner, K. E., Tomlinson, G., Ritvo, P., Irvine, J., & Naglie, G. (2007). Responsiveness of disease-specific and generic utility instruments in prostate cancer patients. Quality of Life Research, 16, 509–522.

    Article  PubMed  Google Scholar 

  13. Badia, X., Roset, M., Herdman, M., & Kind, P. (2001). A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Medical Decision Making, 21, 7–16.

    Article  PubMed  CAS  Google Scholar 

  14. Burnand, B., Kernan, W. N., & Feinstein, A. R. (1990). Indexes and boundaries for “quantitative significance” in statistical decisions. Journal of Clinical Epidemiology, 43, 1273–1284.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Financial support for this study was provided by grant from DIUE de la Generalitat de Catalunya (2009 SGR 1095); and the Catalan Agency for Health Information, Assessment and Quality (grant AATRM 436/05/2008). The funding agreement ensures the authors’ independence in designing the study, interpreting the data, and writing and publishing the report.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Montse Ferrer.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ávila, M., Pardo, Y., Castells, M. et al. Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS). Qual Life Res 23, 2481–2487 (2014). https://doi.org/10.1007/s11136-014-0701-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-014-0701-0

Keywords

Navigation